Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Formin-binding protein 1 (FNBP1; also known as FBP17) is a scaffolding protein that belongs to the F-BAR (FCH-Bin/Amphiphysin/Rvs) domain family, characterized by its ability to bind curved membranes and regulate actin cytoskeleton dynamics[1][5]. FNBP1 contains several functional domains, including an N-terminal FCH domain, coiled-coil domains, a proline-rich motif, a Rho family protein-binding domain, and a C-terminal SH3 domain[1][5][6]. It participates in membrane tubulation, endocytosis, and the assembly of actin-rich cell protrusions (e.g., filopodia, pseudopodia), partly by recruiting N-WASP to activate Arp2/3-mediated actin polymerization[5]. FNBP1 interacts with proteins such as dynamin, tankyrase, and sorting nexin 2, and is considered integral to the migration and invasion capacities of aggressive tumor cells[2][3][5]. Its expression and function are context-dependent, influencing tumor prognosis and immune cell infiltration in several cancer types[2]. No direct pharmacological modulators are currently known.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Formin-binding protein 1 (FNBP1).